A Clinical Trial to Assess Pharmacokinetic Profiles and Safety of IVL3004

Status:
Not yet recruiting

Trial end date:
2024-03-31

Target enrollment:

Participant gender:

Phase 1

Inventage Lab., Inc.

Naltrexone